These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20583317)

  • 1. Skin sensitization, false positives and false negatives: experience with guinea pig assays.
    Basketter DA; Kimber I
    J Appl Toxicol; 2010 Jul; 30(5):381-6. PubMed ID: 20583317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.
    Basketter DA; Gerberick GF; Kimber I
    Cutan Ocul Toxicol; 2007; 26(4):293-301. PubMed ID: 18058304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information derived from sensitization test methods: test sensitivity, false positives and false negatives.
    Basketter DA; Kimber I
    Contact Dermatitis; 2007 Jan; 56(1):1-4. PubMed ID: 17177701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH.
    Basketter D; Ball N; Cagen S; Carrillo JC; Certa H; Eigler D; Garcia C; Esch H; Graham C; Haux C; Kreiling R; Mehling A
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):90-6. PubMed ID: 19523501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
    Kreiling R; Hollnagel HM; Hareng L; Eigler D; Lee MS; Griem P; Dreessen B; Kleber M; Albrecht A; Garcia C; Wendel A
    Food Chem Toxicol; 2008 Jun; 46(6):1896-904. PubMed ID: 18343554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The local lymph node assay being too sensitive?
    Hans-Werner V; Jürgen AH
    Arch Toxicol; 2005 Dec; 79(12):721-8. PubMed ID: 16025312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
    Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
    Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance standards and alternative assays: practical insights from skin sensitization.
    Kolle SN; Basketter DA; Casati S; Stokes WS; Strickland J; van Ravenzwaay B; Vohr HW; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):278-85. PubMed ID: 23279805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
    Roberts DW; Schultz TW; Api AM
    Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local lymph node assay (LLNA): comparison of different protocols by testing skin-sensitizing epoxy resin system components.
    Gamer AO; Nies E; Vohr HW
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):290-8. PubMed ID: 18824053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.